Affiliation:
1. Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492, USA.
Abstract
Thirteen oral cephems (cefprozil, loracarbef, cefaclor, cefuroxime axetil, cefpodoxime proxetil, cefetamet pivoxil, cefixime, cefdinir, cefadroxil, cephradine, cephalexin, cefatrizine, and cefroxadine), the cephalosporin class representative cephalothin, cefazolin, and the macrolides erythromycin, clarithromycin, and azithromycin were compared for their antibacterial activities against 790 recent clinical isolates. These oral agents differed in their spectra and antibacterial potencies against community-acquired pathogens.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference12 articles.
1. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae;Barry A. L.;Am. J. Clin. Pathol.,1985
2. Reassessment of the ``class'' concept of disk susceptibility testing;Barry A. L.;Am. J. Clin. Pathol.,1978
3. Duval J. 1985. Evolution and epidemiology of MLS resistance. J. Antimicrob. Chemother. 16(Suppl. A):137-149.
4. Inability of cephalothin testing to predict cefprozil susceptibility;Fung-Tomc J.;J. Clin. Microbiol.,1991
5. Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990;Geslin P.;Clin. Infect. Dis.,1992
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献